Literature DB >> 22281894

Squamous cell carcinoma of the penis: clinicopathologic study of 34 cases.

Fabiana Braga França Wanick1, Tullia Cuzzi Teichner, Rosane Silva, Mônica Maria Ferreira Magnanini, Lucia Maria Soares de Azevedo.   

Abstract

BACKGROUND: In Brazil, the incidence of penile cancer is 8.3 cases per 100,000 population, in contrast to 0.7 in Europe and the United States. 95% of these cases correspond to squamous cell carcinoma (SCC). It is usually diagnosed late.
OBJECTIVES: To describe the clinicopathologic features of squamous cell carcinoma of the penis registered at the Hospital between 1978 and 2004.
METHODS: A cross-sectional observational study. We included cases of squamous cell carcinoma of the penis that were histologically confirmed. Those patients who responded to the study call were evaluated in person, while others had their data researched in medical records.
RESULTS: 34 patients with squamous cell carcinoma of the penis were registered: 8 in situ and 26 invasive, with a mean age of 54.7 ± 22.4 and 64,7 ± 12.5 years, respectively. Glans cancer was involved in 91.1% of the cases and the foreskin in 41.1%. SCC in situ exhibited papules or erythema and erosion, usually smaller than 2 cm. Invasive SCC was characterized by ulcers and/or vegetation, usually single and bigger than 2 cm. Of the invasive cases, 80.8% were well differentiated; half was in the TNM stage I and the remaining in stages II to IV. 16 patients had their penis amputated, and 3 died.
CONCLUSIONS: Cancer of the penis is rare and affects adults of all ages and treatment can be aggressive. The nonspecific clinical appearance of early lesions, insufficient medical training in skin lesions and lack of routine diagnostic investigation, treatment and follow up of these cases contribute to the poor prognosis of this neoplasm.

Entities:  

Mesh:

Year:  2011        PMID: 22281894     DOI: 10.1590/s0365-05962011000600004

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  5 in total

1.  Conservative treatment of penile carcinoma - a retrospective study of 10 years.

Authors:  Neide Pereira; Ana Rita Cabral; Ricardo Vieira; Américo Figueiredo
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  Prognostic utility of SOX2, STAT3, and CD44high/CD24low expression in penile cancer.

Authors:  Felipe Dubourcq de Barros; Leuridan Cavalcante Torres; Carolline Araujo; Felipe da Silva Marinho; Beatriz Cavalcanti Dubourcq; Luís Cavalcanti Dubourcq; Gustavo Cardoso Guimarães
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-01       Impact factor: 4.322

3.  Prevalence of human papillomavirus in penile malignant tumors: viral genotyping and clinical aspects.

Authors:  Isaura Danielli Borges de Sousa; Flávia Castello Branco Vidal; João Paulo Castello Branco Vidal; George Castro Figueira de Mello; Maria do Desterro Soares Brandão Nascimento; Luciane Maria Oliveira Brito
Journal:  BMC Urol       Date:  2015-02-24       Impact factor: 2.264

4.  Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer.

Authors:  Jun Kasuga; Takashi Kawahara; Daiji Takamoto; Sachi Fukui; Takashi Tokita; Tomoyuki Tadenuma; Masaki Narahara; Syusei Fusayasu; Hideyuki Terao; Koji Izumi; Hiroki Ito; Yusuke Hattori; Jun-Ichi Teranishi; Takeshi Sasaki; Kazuhide Makiyama; Yasuhide Miyoshi; Masahiro Yao; Yasushi Yumura; Hiroshi Miyamoto; Hiroji Uemura
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

5.  Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer.

Authors:  Chen Hu; Yu Bai; Jun Li; Guoyin Zhang; Libo Yang; Chengwei Bi; Bin Zhao; Yong Yang; Ruiqian Li; Hongyi Wu; Qilin Wang; Yang Qin
Journal:  BMC Urol       Date:  2020-05-27       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.